Information

You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

loading
MedImmune Suit Ends;Syngenta,Monsanto Cross-License Genetic Engineering Technology;More Litigation Between StemCells and Neuralstem;Mixed Decision in Dako Case;Writ of Mandamus Denied in PCR Case;How Far Does Safe Harbor Reach?;Anticoagulant Patent Found Unenforceable